Harvard Catalyst | The Harvard Clinical and Translational Science Center

Harvard Catalyst | The Harvard Clinical and Translational Science Center Harvard Catalyst brings together the intellectual force, technologies, and clinical expertise of Har

Harvard Catalyst brings together the intellectual force, technologies, and clinical expertise of Harvard University and its affiliates and partners to reduce the burden of human illness.

12/22/2025

🎤 Most popular with listeners in 2025:

Earlier this year, Alicia Whittington, the Football Players Health Study director of engagement and health equity research, joined our ThinkResearch Podcast team to discuss her work on the study, including a family initiative and resources for former NFL players.

Listen: hvrdct.me/b27650

Calling all Harvard-affiliated NIH K grant applicantsFree consultation service: Receive tailored feedback from peers and...
12/17/2025

Calling all Harvard-affiliated NIH K grant applicants

Free consultation service: Receive tailored feedback from peers and one of our distinguished mentors on your draft Specific Aims pages and career development plans.

Learn more & apply by January 7: hvrdct.me/8dc21e

12/16/2025

Our most popular interview of 2025

Robert Waldinger leads the Harvard Study on Adult Development, one of the longest-running scientific investigations into human happiness and wellbeing.

Earlier this year, Waldinger sat down with us to discuss the secret to happiness: hvrdct.me/af41a1

12/15/2025

Genomic Medicine in Clinical Practice⁠

Designed for healthcare professionals, researchers, and medical students who are interested in learning more about genomic medicine. ⁠

This self paced, online course covers five modules: Foundational Components; Genomic Variation and Laboratory Analysis; Clinical Genetic Testing; Preventative Genomic Screening; and Ethical, Legal, and Social Issues. ⁠

Free for Harvard-affiliated researchers & open to others for a fee.

Learn more & register: hvrdct.me/uc4

12/12/2025

How can imaging be utilized to advance cardiology research?

Diana Lopez, of Brigham and Women's Hospital, shares insights into the future of this field. Read about her innovative research using PET imaging to better understand and treat heart disease: hvrdct.me/b3bd2f

Harvard-affiliated fellows, trainees & researchers: Our free consultations can support you at any stage in your career.⁠...
12/10/2025

Harvard-affiliated fellows, trainees & researchers: Our free consultations can support you at any stage in your career.⁠

Check out and sign up for consultations in the areas of biostatistics, bioinformatics, QA/QI, community engagement, NIH K Grants and more: hvrdct.me/fpr

Hybrid course (virtual and live sessions) for graduate students, fellows, and junior faculty: Plan and develop your own ...
12/08/2025

Hybrid course (virtual and live sessions) for graduate students, fellows, and junior faculty: Plan and develop your own clinical trial proposal supported by biostatistical consultations.⁠

Course format: Online lectures and peer feedback. ⁠

Apply by February 9: hvrdct.me/f36f50

From the archives: Five Questions with Harvard T.H. Chan School of Public Health biostatistician LJ Wei. A consultant fo...
12/05/2025

From the archives: Five Questions with Harvard T.H. Chan School of Public Health biostatistician LJ Wei. A consultant for Harvard Catalyst Biostatistics, Wei shares why methodology matters and explains the power of staying curious. ⁠

Read interview: hvrdct.me/pza

Drawing on a team of highly skilled biostatisticians from the Harvard academic medical and hospital community, we offer consultations and expertise on a range of relevant areas to researchers as they launch new clinical and translational projects.

12/03/2025

From the archives: Why should researchers make friends with the IRB?

Kim Serpico, associate director of IRB operations for the Harvard Longwood campus, shares her thoughts.⁠

Read interview: hvrdct.me/7e1a89

Biostatistics Journal Club: Tumor factors (e.g., stage) are important predictors of prognosis for aggressive forms of br...
11/28/2025

Biostatistics Journal Club: Tumor factors (e.g., stage) are important predictors of prognosis for aggressive forms of breast cancer, but may be intermediates between pre-diagnosis risk factors and mortality. Typically, separate models are fit for incidence and mortality post-diagnosis.

Join Bernie Rosner, of Harvard T.H. Chan School of Public Health & Brigham and Women's Hospital, on the use of a multi-state model for breast cancer incidence.

Register: hvrdct.me/40c926

Happy Thanksgiving to all researchers, MDs, and scientists at Harvard and beyond. 🍁⁠We're thankful today and everyday fo...
11/27/2025

Happy Thanksgiving to all researchers, MDs, and scientists at Harvard and beyond. 🍁

We're thankful today and everyday for the vital work you do to help improve human health.

Hybrid course (virtual and live sessions) for graduate students, fellows, and junior faculty: Plan and develop your own ...
11/26/2025

Hybrid course (virtual and live sessions) for graduate students, fellows, and junior faculty: Plan and develop your own clinical trial proposal supported by biostatistical consultations.⁠

Course format: Online lectures and peer feedback.

Apply by February 9: hvrdct.me/f36f50

Address

1635 Tremont Street
Boston, MA
02120

Website

http://www.twitter.com/harvardcatalyst

Alerts

Be the first to know and let us send you an email when Harvard Catalyst | The Harvard Clinical and Translational Science Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Harvard Catalyst | The Harvard Clinical and Translational Science Center:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram